The Next Generation of Human Immunodeficiency Virus Protease Inhibitors: Targeting Viral Resistance
- 1 January 2000
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with RitonavirThe Journal of Clinical Pharmacology, 1998
- HIV protease inhibitorsCurrent Opinion in Infectious Diseases, 1997
- Decay characteristics of HIV-1-infected compartments during combination therapyNature, 1997
- Mutational Anatomy of an HIV-1 Protease Variant Conferring Cross-resistance to Protease Inhibitors in Clinical TrialsJournal of Biological Chemistry, 1996
- Clinical isolates of HIV-1 contain few pre-existing proteinase inhibitor resistance-conferring mutationsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Thegagprecursor contains a specific HIV‐1 protease cleavage site between the NC (P7) and P1 proteinsFEBS Letters, 1993
- Comparison of the HIV‐1 and HIV‐2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag‐Pol polyproteinsFEBS Letters, 1991
- HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteinsBiochemical and Biophysical Research Communications, 1988